CDSCO Panel Approves Sanofi's Protocol Amendment Proposal For Study of SAR443122 in Ulcerative Colitis Dr. Divya Colin17 March 2024 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
CDSCO Panel Grants Roche's Protocol Amendment Proposal For Crovalimab study Dr. Divya Colin16 March 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
CDSCO Panel grants Pfizer's Protocol Amendment for Anti-cancer Drug Palbociclib study Dr. Divya Colin16 March 2024 4:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
CDSCO Panel Grants Roche's Protocol Amendment Proposal For Anti-cancer Drug Giredestrant Dr. Divya Colin24 Feb 2024 5:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
CDSCO Panel Approves AstraZeneca's Protocol Amendment Proposal to Study Capivasertib Plus Abiraterone Dr. Divya Colin18 Feb 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
CDSCO Panel Approves Novartis Protocol Amendment Proposal For Multiple Sclerosis Drug Ofatumumab Dr. Divya Colin11 Feb 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
CDSCO Panel Grants Bristol-Myers Squibb's Protocol Amendment proposal for Mavacamten Dr. Divya Colin7 Feb 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved the drug major...
CDSCO Panel grants Novartis Protocol Amendment proposal for Remibrutinib study in Relapsing Multiple Sclerosis Dr. Divya Colin5 Feb 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
CDSCO Panel Approves Roche's Protocol Amendment Proposal for Anticancer Drug Giredestrant Dr. Divya Colin4 Feb 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
CDSCO Panel Approves Sanofi's Protocol Amendment proposal for COPD drug Itepekimab Dr. Divya Colin21 Jan 2024 5:00 PM ISTNew Delhi: The Subject Expert Panel (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major Sanofi's...
CDSCO Panel Approves Novo Nordisk Protocol Amendment Proposal for Concizumab Dr. Divya Colin13 Jan 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
CDSCO Panel grants Wockhardt's Protocol Amendment Proposal For Cefepime Zidebactam Dr. Divya Colin11 Jan 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
